Improving warfarin management- identifying risk factors for bleeding and improving monitoring mechanisms [ 2008 - 2012 ]

Research Grant

Researchers: A/Pr Sue Evans (Principal investigator)

Brief description Warfarin is a drug commonly used in the elderly to prevent blood clots. While a very effective drug, it is also a dangerous drug and should be closely monitored. While we know many of the reasons why problems occur, we do not know whether organisation of care, mental health or social issues such as community support influence how well warfarin is managed. These are important questions to answer, so that we can make significant inroads into preventing death and disability from warfarin.

Funding Amount $AUD 291,309.62

Funding Scheme Early Career Fellowships

Notes Public Health (Australia) ECF